<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36313487</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Cross-sectional analysis of clinical aspects in patients with long-COVID and post-COVID syndrome.</ArticleTitle><Pagination><StartPage>979152</StartPage><MedlinePgn>979152</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">979152</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2022.979152</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Regarding pathogenesis, clinical manifestations, at-risk individuals, and diagnostic methods for stratifying patients for therapeutic approaches, our understanding of post-COVID syndrome is limited. Here, we set out to assess sociodemographic and clinical aspects in patients with the long-COVID and post-COVID syndrome.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed a cross-sectional analysis of patients presenting at our specialized university hospital outpatient clinic. We assessed patients' clinical presentation, fatigue, symptoms of depression and anxiety, and impairment of smell.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 101 patients were included (73.3% female), of whom 78.2% had a mild course of COVID-19. At presentation, 93.1% suffered from fatigue, 82.2% from impaired concentration, and 79.2% from impaired memory, 53.5% had impaired sleep. The most common secondary diagnosis found in our cohort was thyroid disease. Fatigue analysis showed that 81.3% of female and 58.8% of male patients had severe combined fatigue. Female gender was an independent risk factor for severe fatigue (severe cognitive fatigue OR = 8.045, <i>p</i> = 0.010; severe motor fatigue OR = 7.698, <i>p</i> = 0.013). Males suffered from more depressive symptoms, which correlated positively with the duration of symptom onset. 70.3% of patients with anamnestic smell impairment had hyposmia, and 18.9% were anosmic.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Most long-COVID patients suffered from severe fatigue, with the female sex as an independent risk factor. Fatigue was not associated with symptoms of depression or anxiety. Patients with long-COVID symptoms should receive an interdisciplinary diagnostic and therapeutic approach depending on the clinical presentation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Schulze, Charles James, Trampe, Richter, Pakeerathan, Siems, Ayzenberg, Gold and Faissner.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charles James</LastName><ForeName>Jeyanthan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trampe</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakeerathan</LastName><ForeName>Thivya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siems</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayzenberg</LastName><ForeName>Ilya</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faissner</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">smell disorder</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>4</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36313487</ArticleId><ArticleId IdType="pmc">PMC9614029</ArticleId><ArticleId IdType="doi">10.3389/fneur.2022.979152</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. (2020) 324:2251&#x2013;2. 10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. . Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. (2020) 17:e1003346. 10.1371/journal.pmed.1003346</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003346</ArticleId><ArticleId IdType="pmc">PMC7508369</ArticleId><ArticleId IdType="pubmed">32960881</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY, et al. . Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity. Clin Infect Dis. (2021) 73:e2932&#x2013;42. 10.1093/cid/ciaa1280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1280</ArticleId><ArticleId IdType="pmc">PMC7499509</ArticleId><ArticleId IdType="pubmed">32856707</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2 - the story so far. Nat Rev Neurol. (2021) 17:65&#x2013;6. 10.1038/s41582-020-00453-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00453-w</ArticleId><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. (2021) 8:100186. 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, Li X, R&#xe4;uber S, Mausberg AK, B&#xf6;rsch AL, Hartlehnert M, et al. . Neurological manifestations of COVID-19 feature t cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity. (2021) 54:164&#x2013;75. 10.1016/j.immuni.2020.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7831653</ArticleId><ArticleId IdType="pubmed">33382973</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy WJ, Longo DL. A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N Engl J Med. (2021) 386:394&#x2013;6. 10.1056/NEJMcibr2113694</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2113694</ArticleId><ArticleId IdType="pubmed">34818473</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G, Newcomb R, Cowl CT, Murad MH, Breeher L, Miller S, et al. . Post-COVID-19 syndrome (Long Haul Syndrome): description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort. Mayo Clin Proc. (2021) 96:1782&#x2013;91. 10.1016/j.mayocp.2021.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection . A minimal common outcome measure is set for COVID-19 clinical research. Lancet Infect Dis. (2020) 20:e192&#x2013;e197. 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner IK, Raselli C, St&#xf6;cklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. (2009) 15:1509&#x2013;17. 10.1177/1352458509348519</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458509348519</ArticleId><ArticleId IdType="pubmed">19995840</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. (2003) 1:29. 10.1186/1477-7525-1-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-1-29</ArticleId><ArticleId IdType="pmc">PMC183845</ArticleId><ArticleId IdType="pubmed">12914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. &#x2018;Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination, and olfactory threshold. Chem Senses. (1997) 22:39&#x2013;52. 10.1093/chemse/22.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/22.1.39</ArticleId><ArticleId IdType="pubmed">9056084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, H&#xe4;hner A, Witt M, Landis BN. Examination of the sense of smell. HNO. (2007) 55:827&#x2013;37. 10.1007/s00106-007-1593-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00106-007-1593-x</ArticleId><ArticleId IdType="pubmed">17676288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfensberger M, Schnieper I. Sniffin'Sticks: a new system for olfactory assessment in routine clinical practice. HNO. (1999) 47:629&#x2013;36. 10.1007/s001060050436</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001060050436</ArticleId><ArticleId IdType="pubmed">10463115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortu&#xf1;o R. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med. (2021) 10. 10.1101/2021.06.25.21259372</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.25.21259372</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control Prevention N.C.F.E.a.Z.I.D.N., Division of High-Consequence Pathogens and Pathology. What is ME/CFS?  (2021). Available online at: https://www.cdc.gov/me-cfs/about/index.html (accessed January 27, 2021).</Citation></Reference><Reference><Citation>Rollnik JD. Chronic fatigue syndrome: a critical review. Fortschr Neurol Psychiatr. (2017) 85:79&#x2013;85. 10.1055/s-0042-121259</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-121259</ArticleId><ArticleId IdType="pubmed">28235209</ArticleId></ArticleIdList></Reference><Reference><Citation>Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, et al. . A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. MBio. (2012) 3:e00266&#x2013;12. 10.1128/mBio.00266-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00266-12</ArticleId><ArticleId IdType="pmc">PMC3448165</ArticleId><ArticleId IdType="pubmed">22991430</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett SV, Clark IA. Inflammatory fatigue and sickness behaviour - lessons for diagnosing and managing chronic fatigue syndrome. J Affect Disord. (2012) 141:130&#x2013;42. 10.1016/j.jad.2012.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2012.04.004</ArticleId><ArticleId IdType="pubmed">22578888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford G, Manning P, Newton JL. Understanding muscle dysfunction in chronic fatigue syndrome. J Aging Res. (2016) 2016:2497348. 10.1155/2016/2497348</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2497348</ArticleId><ArticleId IdType="pmc">PMC4779819</ArticleId><ArticleId IdType="pubmed">26998359</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, et al. . Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19. Ann Neurol. (2022) 91:367&#x2013;79. 10.1002/ana.26286</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A, et al. . Autoantibodies to vasoregulative g-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. (2021) 10:3675. 10.3390/jcm10163675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. . Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med (Lausanne). (2021) 8:754667. 10.3389/fmed.2021.754667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M, Garc&#xed;a-S&#xe1;nchez C, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. . Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol. (2022) 269:3990&#x2013;9. 10.1007/s00415-022-11141-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter D, Schulze H, James J. C., Siems N., Trampe N, Gold R, et al. (2022). Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study. J Neurol 1&#x2013;7. 10.1007/s00415-022-11154-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11154-3</ArticleId><ArticleId IdType="pmc">PMC9098142</ArticleId><ArticleId IdType="pubmed">35552501</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, Delgado-Alonso C, D&#xed;ez-Cirarda M, Mart&#xed;nez-Petit &#xc1;, Oliver-Mas S, Delgado-&#xc1;lvarez A, et al. . Neuropsychological predictors of fatigue in post-COVID syndrome. J Clin Med. (2022) 11. 10.3390/jcm11133886</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133886</ArticleId><ArticleId IdType="pmc">PMC9267301</ArticleId><ArticleId IdType="pubmed">35807173</ArticleId></ArticleIdList></Reference><Reference><Citation>Schambeck SE, Crowell CS, Wagner KI, D'ippolito E, Burrell T, Mijo&#x10d;evi&#x107; H, et al. . Phantosmia, parosmia, and dysgeusia are prolonged and late-onset symptoms of COVID-19. J Clin Med. (2021) 10:5266. 10.3390/jcm10225266</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225266</ArticleId><ArticleId IdType="pmc">PMC8618742</ArticleId><ArticleId IdType="pubmed">34830550</ArticleId></ArticleIdList></Reference><Reference><Citation>Huart C, Philpott CM, Altundag A, Fjaeldstad AW, Frasnelli J, Gane S, et al. . Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. Int Forum Allergy Rhinol. (2021) 11:1041&#x2013;6. 10.1002/alr.22788</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22788</ArticleId><ArticleId IdType="pmc">PMC8251281</ArticleId><ArticleId IdType="pubmed">33728824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>